BOOK
Novel Approaches to the Management of Sleep-Disordered Breathing, An Issue of Sleep Medicine Clinics, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Sleep Medicine Clinics focuses on Novel Therapies for Sleep-Disorderd Breathing. Article topics include: The problems and pitfalls with current approaches to managing sleep disordered breathing; New approaches to diagnosing sleep disordered breathing; Monitoring progress and adherence with PAP therapy for OSA; The future of dental approaches for the treatment of OSA; Pharmacologic approaches for the treatment of OSA; Novel therapies for the treatment of central sleep apnea; Advances and new approaches to managing sleep disordered breathing related to chronic pulmonary disease; The role of big data in the management of sleep disordered breathing; Using genes and biomarkers to assess risk and identify optimal treatments for patients with sleep disordered breathing, and more!
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Novel Approaches tothe Management ofSleep-Disordered Breathing | i | ||
Copyright\r | ii | ||
CME Accreditation Page | iii | ||
PROGRAM OBJECTIVE | iii | ||
TARGET AUDIENCE | iii | ||
LEARNING OBJECTIVES | iii | ||
ACCREDITATION | iii | ||
DISCLOSURE OF CONFLICTS OF INTEREST | iii | ||
UNAPPROVED/OFF-LABEL USE DISCLOSURE | iii | ||
TO ENROLL | iv | ||
METHOD OF PARTICIPATION | iv | ||
CME INQUIRIES/SPECIAL NEEDS | iv | ||
SLEEP MEDICINE CLINICS\r | v | ||
FORTHCOMING ISSUES | v | ||
September 2016 | v | ||
December 2016 | v | ||
March 2017 | v | ||
RECENT ISSUES | v | ||
March 2016 | v | ||
December 2015 | v | ||
September 2015 | v | ||
Contributors | vii | ||
CONSULTING EDITOR | vii | ||
EDITOR | vii | ||
AUTHORS | vii | ||
Contents | ix | ||
Preface: Novel Approaches to the Management of Sleep-Disordered Breathing: Reviewing the Past and Looking Into the Future\r | ix | ||
New Approaches to Diagnosing Sleep-Disordered Breathing\r | ix | ||
New Approaches to Positive Airway Pressure Treatment in Obstructive Sleep Apnea\r | ix | ||
Monitoring Progress and Adherence with Positive Airway Pressure Therapy for Obstructive Sleep Apnea: The Roles of Telemedic\r | ix | ||
Novel Approaches to the Management of Sleep-Disordered Breathing\r | ix | ||
Novel Surgical Approaches for the Treatment of Obstructive Sleep Apnea\r | x | ||
Pharmacologic Approaches to the Treatment of Obstructive Sleep Apnea\r | x | ||
The Challenges of Precision Medicine in Obstructive Sleep Apnea\r | x | ||
Novel Therapies for the Treatment of Central Sleep Apnea\r | x | ||
The Role of Big Data in the Management of Sleep-Disordered Breathing\r | xi | ||
Advances and New Approaches to Managing Sleep-Disordered Breathing Related to Chronic Pulmonary Disease\x0B | xi | ||
Preface\rNovel Approaches to the Management of Sleep-Disordered Breathing: Reviewing the Past and Looking Into the Future | xiii | ||
New Approaches to Diagnosing Sleep-Disordered Breathing | 143 | ||
Key points | 143 | ||
DETECTING THE PRESENCE OF EVENTS: DIAGNOSTIC AND SCREENING TECHNOLOGY | 143 | ||
Home Sleep Testing | 144 | ||
Novel Approaches to Screening and Monitoring Sleep Apnea | 144 | ||
Snoring and breathing sounds | 145 | ||
Electrocardiogram | 145 | ||
Motion detection | 145 | ||
AUTOMATED AND COMPUTER-ASSISTED SCORING TECHNOLOGY | 146 | ||
Sleep State and Arousals | 146 | ||
Respiratory Events | 146 | ||
APPROACHES TO DIAGNOSING SLEEP APNEA PATHOPHYSIOLOGY FOR GUIDING TREATMENT DECISIONS | 147 | ||
Upper Airway Collapsibility: Severity | 147 | ||
Upper Airway Muscle Compensation | 148 | ||
Upper Airway Collapsibility: Site | 148 | ||
High Loop Gain | 148 | ||
Arousal Threshold, Sleep State Instability | 149 | ||
SUMMARY | 149 | ||
REFERENCES | 149 | ||
New Approaches to Positive Airway Pressure Treatment in Obstructive Sleep Apnea | 153 | ||
Key points | 153 | ||
INTRODUCTION | 153 | ||
CONTINUOUS POSITIVE AIRWAY PRESSURE UNITS | 153 | ||
MODES OF CONTINUOUS POSITIVE AIRWAY PRESSURE DELIVERY | 153 | ||
AUTOTITRATING POSITIVE AIRWAY PRESSURE | 154 | ||
AUTOTRIAL MODE AND AUTOMATIC PRESSURE ADJUSTMENT (CONTINUOUS POSITIVE AIRWAY PRESSURE CHECK) | 154 | ||
EXPIRATORY RELIEF | 154 | ||
MASK INTERFACES | 155 | ||
HEATED HUMIDIFICATION | 155 | ||
HEATED TUBING | 155 | ||
COMPLIANCE MONITORING | 156 | ||
COMPLIANCE MONITORING BY THE PATIENT | 156 | ||
FUTURE DIRECTIONS OF POSITIVE AIRWAY PRESSURE TREATMENT IN OBSTRUCTIVE SLEEP APNEA | 157 | ||
REFERENCES | 157 | ||
Monitoring Progress and Adherence with Positive Airway Pressure Therapy for Obstructive Sleep Apnea | 161 | ||
Key points | 161 | ||
INTRODUCTION | 161 | ||
OVERVIEW OF TELEMEDICINE | 162 | ||
Definitions | 162 | ||
Asynchronous Telemedicine | 162 | ||
Overview | 162 | ||
Electronic messaging | 162 | ||
Remote monitoring | 163 | ||
Automated and self-management mechanisms | 163 | ||
SLEEP MEDICINE AND TELEMEDICINE | 163 | ||
Overview | 163 | ||
Telemedicine and Obstructive Sleep Apnea Education | 164 | ||
Telemedicine and Continuous Positive Airway Pressure Follow-up | 164 | ||
Overview | 164 | ||
Wireless transfer of continuous positive airway pressure data | 165 | ||
Automated mechanisms and self-management continuous positive airway pressure follow-up platforms | 165 | ||
Current Sleep Telemedicine Solutions | 166 | ||
HEALTH INFORMATION TECHNOLOGY: THE DEVELOPING ECOSYSTEM | 167 | ||
Overview | 167 | ||
Sleep Mobile Device Applications and Wearable Sensors | 167 | ||
Background | 167 | ||
Types of devices | 167 | ||
Activity trackers | 168 | ||
Practical implications | 168 | ||
Peer-Based Follow-up | 168 | ||
Electronic Health Records and Technology Integration | 168 | ||
General concepts | 168 | ||
Device integration | 169 | ||
Data analytics: population health management | 169 | ||
Work flow integration: clinical care pathways | 169 | ||
SUMMARY | 170 | ||
REFERENCES | 170 | ||
Novel Approaches to the Management of Sleep-Disordered Breathing | 173 | ||
Key points | 173 | ||
INTRODUCTION | 173 | ||
Surgical Treatment Options for Obstructive Sleep Apnea | 174 | ||
Bariatric surgery | 174 | ||
Uvulopalatopharyngoplasty | 174 | ||
Oral Appliances | 174 | ||
Tongue-retaining device | 175 | ||
Mandibular repositioning devices | 176 | ||
Design selection of mandibular repositioning devices | 177 | ||
Oral Appliance Calibration Technology | 178 | ||
Multiple sleep testing titration | 178 | ||
Predictive jaw positioning: real-time sleep testing | 178 | ||
Predicting starting jaw position: measurement-based | 178 | ||
Oral Appliance Adherence Monitoring Technology | 180 | ||
Noncustom Oral Appliances | 180 | ||
Positional Therapy | 180 | ||
Expiratory Positive Airway Pressure | 181 | ||
Pharmacologic Treatment of Obstructive Sleep Apnea | 182 | ||
Predictive Models for Selecting Alternative Therapies | 182 | ||
Phenotyping models: oral appliance therapy | 183 | ||
The role of pharyngeal muscle response | 183 | ||
Oral Myofunctional Therapy | 183 | ||
Orthodontics | 184 | ||
Combination Therapy | 184 | ||
SUMMARY | 185 | ||
SUPPLEMENTARY DATA | 186 | ||
REFERENCES | 186 | ||
Novel Surgical Approaches for the Treatment of Obstructive Sleep Apnea | 189 | ||
Key points | 189 | ||
INTRODUCTION: THE ROLE OF SURGICAL THERAPY | 189 | ||
Novel Diagnostic Evaluation Approach | 190 | ||
Drug-induced sedation endoscopy | 190 | ||
Background | 190 | ||
Technique | 190 | ||
Phenotyping the upper airway | 191 | ||
Indications | 192 | ||
Future | 192 | ||
Novel Airway Surgery Approach | 193 | ||
Expansion sphincter pharyngoplasty | 193 | ||
Background | 193 | ||
Need for procedure modifications | 193 | ||
Improving effectiveness | 193 | ||
Reducing morbidity | 193 | ||
Indications | 194 | ||
Surgical technique | 194 | ||
Outcomes data | 194 | ||
Future | 194 | ||
Novel Therapeutic Approach | 194 | ||
Hypoglossal nerve stimulation therapy | 194 | ||
Background | 194 | ||
Electrical stimulation of the upper airway | 195 | ||
Human pilot and feasibility studies | 196 | ||
Anatomic effect on the upper airway | 196 | ||
Surgical technique | 197 | ||
Follow-up | 198 | ||
Indications | 198 | ||
Data from the stimulation therapy for apnea reduction trial | 199 | ||
Discussion | 199 | ||
Comparison of upper airway stimulation to other obstructive sleep apnea treatments | 199 | ||
Future directions | 200 | ||
SUMMARY | 200 | ||
REFERENCES | 200 | ||
Pharmacologic Approaches to the Treatment of Obstructive Sleep Apnea | 203 | ||
Key points | 203 | ||
INTRODUCTION | 203 | ||
Upper Airway Anatomy or Collapsibility | 203 | ||
The Challenges of Precision Medicine in Obstructive Sleep Apnea | 213 | ||
Key points | 213 | ||
SLEEP-DISORDERED BREATHING AND OBSTRUCTIVE SLEEP APNEA | 213 | ||
PEDIATRIC OBSTRUCTIVE SLEEP APNEA | 214 | ||
ADULT OBSTRUCTIVE SLEEP APNEA | 214 | ||
TREATMENT OF OBSTRUCTIVE SLEEP APNEA | 214 | ||
THE LONG AND COMPLEX ROAD TO BIOMARKER DISCOVERY AND IMPLEMENTATION | 215 | ||
TRANSCRIPTOMICS | 216 | ||
CIRCULATING MICRORNA | 218 | ||
SINGLE-NUCLEOTIDE POLYMORPHISMS | 219 | ||
EPIGENOMICS | 220 | ||
PROTEOMICS | 221 | ||
SUMMARY AND FUTURE DIRECTIONS | 221 | ||
REFERENCES | 221 | ||
Novel Therapies for the Treatment of Central Sleep Apnea | 227 | ||
Key points | 227 | ||
INTRODUCTION | 227 | ||
CENTRAL SLEEP APNEA AND PERIODIC BREATHING IN HEART FAILURE | 227 | ||
PREVALENCE OF CENTRAL SLEEP APNEA IN HEART FAILURE | 228 | ||
TREATMENT OF CENTRAL SLEEP APNEA IN HEART FAILURE | 229 | ||
POSITIVE AIRWAY PRESSURE IN THE TREATMENT OF CENTRAL SLEEP APNEA IN HEART FAILURE | 229 | ||
TRANSVENOUS PHRENIC NERVE STIMULATION FOR TREATMENT OF CENTRAL SLEEP APNEA IN HEART FAILURE | 231 | ||
OPIOIDS-INDUCED CENTRAL SLEEP APNEA | 233 | ||
TREATMENT OPTIONS FOR OPIOID-INDUCED CENTRAL SLEEP APNEA | 234 | ||
Positive Airway Pressure Devices | 234 | ||
AMPAKINE THERAPY FOR COUNTERING CENTRAL RESPIRATORY DEPRESSION | 234 | ||
Respiratory Neural Control and the Importance of Amino-3-hydroxy-5-methyl-4-isoxazolepropionate Receptor Activation | 235 | ||
Preclinical Rodent Data Demonstrating the Efficacy of Ampakines for Countering Opioid-Induced Respiratory Depression | 235 | ||
In Vitro Rodent Studies | 235 | ||
In Vivo Rodent Studies | 236 | ||
Translational Human Data Demonstrating the Efficacy of Ampakines for Countering Opioid-Induced Respiratory Depression | 236 | ||
Additional Applications of Ampakines for Alleviating Respiratory Depression | 236 | ||
SUMMARY | 236 | ||
REFERENCES | 237 | ||
The Role of Big Data in the Management of Sleep-Disordered Breathing | 241 | ||
Key points | 241 | ||
INTRODUCTION | 241 | ||
CAUSE AND GENETIC PREDISPOSITION | 243 | ||
DIAGNOSIS | 244 | ||
MANAGEMENT | 245 | ||
COMPLICATIONS OF OBSTRUCTIVE SLEEP APNEA | 247 | ||
ASSOCIATIONS WITH OTHER DISORDERS | 247 | ||
DEVELOPING BIG DATA RESOURCES | 248 | ||
ELECTRONIC HEALTH RECORD DATA | 249 | ||
SLEEP MEDICINE BIG DATA RESOURCES | 250 | ||
LIMITATIONS AND CHALLENGES | 252 | ||
SUMMARY | 253 | ||
REFERENCES | 253 | ||
Advances and New Approaches to Managing Sleep-Disordered Breathing Related to Chronic Pulmonary Disease | 257 | ||
Key points | 257 | ||
INTRODUCTION | 257 | ||
SLEEP PHYSIOLOGY, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND SLEEP-DISORDERED BREATHING | 258 | ||
REVIEW OF RECENT DATA REGARDING NOCTURNAL NONINVASIVE VENTILATION ON PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 258 | ||
VOLUME TARGET NONINVASIVE VENTILATION FOR HYPERCAPNIA IN CHRONIC RESPIRATORY FAILURE | 260 | ||
NONINVASIVE VENTILATION REIMBURSEMENT ISSUES | 260 | ||
RECOMMENDATION FOR REVISION OF CURRENT GUIDELINE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT WITH NONINVASIVE VENTIL ... | 262 | ||
HIGH-FLOW HUMIDIFIED OXYGEN DELIVERY DEVICES | 262 | ||
RESPIRATORY STIMULANTS DRUGS FOR CHRONIC RESPIRATORY FAILURE | 262 | ||
SUMMARY | 263 | ||
REFERENCES | 263 |